本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

20.00
-0.1800-0.89%
成交量:2.84万
成交额:56.87万
市值:22.20亿
市盈率:-10.40
高:20.10
开:20.05
低:19.93
收:20.18
52周最高:44.34
52周最低:15.96
股本:1.11亿
流通股本:1.09亿
量比:1.34
换手率:0.03%
股息:- -
股息率:- -
每股收益(TTM):-1.9229
每股收益(LYR):-2.5984
净资产收益率:-28.97%
总资产收益率:-13.29%
市净率:2.92
市盈率(LYR):-7.70

数据加载中...

2025/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

重要事件披露

Form 8-K - Current report
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/16

重要事件披露

Form 8-K - Current report
2025/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report